The Food and Drug Administration on Monday approved a new screening test for colorectal cancer. For many people, a routine blood test is easier to get than a colonoscopy or a fecal sample test. But the blood test, made by Guardant Health of Palo Alto, Calif., comes with a limitation. It is approved for people aged 45 and over who are at average risk for colon cancer. As many as 53,000 Americans are expected to die from colorectal cancer this year.

---

Persons: Guardant, Matt Burns Organizations: Drug Administration, Guardant Health, Palo Locations: Palo Alto, Calif, United States